Related Articles
Effect of entecavir in the treatment of patients with hepatitis B virus‑related compensated and decompensated cirrhosis
[Editorial] Immuno-dermatological processes involved in chronic skin diseases: Highlights of the Second Conference of the Romanian Society for Immuno-Dermatology, Bucharest, September, 2018
Radiation-induced hepatitis B virus reactivation in hepatocellular carcinoma: A case report
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B
Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID‑19 (Review)